Clinical trials
Active, not recruiting Gastrointestinal Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Chongqing Medical University | 1 |
| IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Peking University | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 5 |
| Colorectal Neoplasms | 3 |
| Digestive System Diseases | 2 |
| Gastrointestinal Diseases | 2 |
| Gastrointestinal Stromal Tumors | 2 |
| Stomach Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Colonic Diseases | 1 |
| Colonic Neoplasms | 1 |
| Digestive System Neoplasms | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.